Mechanism, Dosing & Storage: The Complete Comparison
What's Better Mounjaro or Wegovy: Understanding the Core Differences
The fundamental difference between these two prescription-only medicines lies in their mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a single natural fullness hormone, whilst Mounjaro contains tirzepatide, a dual agonist targeting both GIP and GLP-1 receptors. This dual-receptor approach means Mounjaro works on two distinct pathways to reduce appetite and promote satiety. Both treatments require prescription through clinical assessment and must be used alongside a reduced-calorie diet and increased physical activity. Neither treatment can be considered universally "better" as individual response varies significantly between patients.
When evaluating what's better between Mounjaro or Wegovy, consider that both are subject to MHRA additional monitoring and require careful dose escalation. Wegovy follows a five-step escalation from 0.25mg to 2.4mg maintenance dose over 16 weeks, whilst Mounjaro uses six dose levels from 2.5mg to 15mg over approximately 20 weeks. The longer escalation period for Mounjaro may suit patients who prefer more gradual increases, though this extends the time to reach maintenance dosing. Both treatments are manufactured by established pharmaceutical companies and available through EverydayMeds' GPhC-registered pharmacy (#9012878).
Wegovy vs Mounjaro UK Pricing: Complete Cost Comparison
EverydayMeds offers transparent pricing for both treatments with discount codes applied at checkout. Wegovy pricing starts at £79.99 for the 0.25mg starter dose (with FIRST40 for new customers), progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. Bundle options include the Intro Duo (0.25mg & 0.5mg) for £169.99, providing your first two months of treatment in one convenient order. Returning customers benefit from the DOSE25 discount code, ensuring continued value throughout their weight management journey.
Mounjaro pricing follows a different structure due to its distinct dosing schedule, with all doses available through EverydayMeds' comprehensive weight loss collection. When considering what's better financially between Mounjaro or Wegovy, factor in the total treatment duration and your individual dose requirements as determined by your prescriber. Both treatments offer bundle packages for convenience, ensuring Reliable Supply without frequent reordering. The Ultimate Stability Trio for Wegovy provides three months of 2.4mg maintenance supply for £649.99, whilst equivalent Mounjaro maintenance bundles are structured to match the higher mg dosing requirements.
Clinical Evidence: What's Better Mounjaro or Wegovy Based on Trials
Wegovy's efficacy is demonstrated through the comprehensive STEP trial programme, with STEP 1 showing approximately 15% average weight loss at 68 weeks when used alongside diet and exercise (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events, adding significant clinical value beyond weight management. Patients taking Wegovy in clinical trials experienced sustained weight loss over two years in STEP 5, though weight regain occurred when treatment was discontinued.
Mounjaro's clinical evidence comes from the SURMOUNT trials, demonstrating significant efficacy in weight management when used as prescribed. However, comparing trial results head-to-head would be inappropriate due to different trial designs, populations, and endpoints between the STEP and SURMOUNT programmes. Both treatments have undergone rigorous MHRA evaluation and received marketing authorisation for weight management in appropriate patients, making the choice between them a clinical decision rather than a superiority comparison.
How Wegovy Works in Your Weight Management Journey
Wegovy functions as a GLP-1 receptor agonist, mimicking the action of a natural hormone that signals fullness to your brain's appetite centres. Once injected weekly, semaglutide reduces appetite between meals and promotes earlier satiety during eating, helping you feel satisfied with smaller portions. The medication works on the hypothalamus, the brain region controlling hunger and food cravings, potentially reducing the psychological drive to eat beyond nutritional needs. This mechanism supports adherence to a reduced-calorie diet by making portion control feel more natural rather than restrictive. The once-weekly FlexTouch pen delivery system maintains consistent semaglutide levels, providing steady appetite regulation throughout your treatment week. Individual response varies, with some patients noticing appetite changes within the first few doses whilst others require several weeks to experience the full effect.
Ordering Process: Getting Your Wegovy vs Mounjaro Prescription
EverydayMeds streamlines access to both treatments through a comprehensive three-minute online clinical assessment covering your medical history, current medications, and weight management goals. Following submission, a UK-registered prescriber reviews your assessment within three working days (or 24 hours with express service), determining the most appropriate treatment and starting dose for your individual circumstances. Once approved, your prescription-only medicine is dispatched via next-day delivery using specialist cold-chain logistics to maintain temperature integrity throughout transit. Each delivery includes detailed administration instructions, storage guidance, and direct contact information for ongoing clinical support. The process ensures full compliance with MHRA regulations whilst providing convenient access to these advanced weight management treatments from a GPhC-registered pharmacy (#9012878).
Storage and Practical Considerations: Wegovy vs Mounjaro Daily Life
Storage requirements represent a practical advantage for Wegovy in the what's better Mounjaro or Wegovy comparison, offering superior flexibility for travel and daily routine management. Wegovy pens remain stable at room temperature (below 30°C) for up to six weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature stability. This extended stability makes Wegovy more suitable for frequent travellers, business trips, or households where refrigerator access might be temporarily limited. Both treatments require refrigeration at 2-8°C before first use and should never be frozen or exposed to direct sunlight. The FlexTouch pen system used for Wegovy provides intuitive dose administration with clear dosing windows and audible click confirmation, whilst Mounjaro uses a similar but distinct pen design optimised for its higher volume doses.
Dual Mechanism vs Single Target: What's Better for Your Biology
The biological question of what's better between Mounjaro or Wegovy ultimately depends on how your individual metabolism responds to single versus dual hormone pathway targeting. Wegovy's focused GLP-1 approach may suit patients who achieve adequate appetite control through this single mechanism, potentially with fewer adjustment variables to monitor during treatment. Some patients respond optimally to the targeted approach, experiencing significant weight loss and improved satiety with Wegovy's semaglutide formulation.
Mounjaro's dual GIP and GLP-1 receptor targeting theoretically provides additional metabolic benefits through enhanced insulin sensitivity and glucose metabolism alongside appetite regulation. However, more pathways activated doesn't automatically translate to better outcomes for every individual, as response depends on your unique hormone receptor sensitivity and metabolic profile. The choice between single and dual targeting should be made with your prescriber based on your medical history, concurrent conditions, and previous treatment responses rather than theoretical mechanism advantages.
Making Your Decision: Both Available from EverydayMeds
Rather than determining what's definitively better between Mounjaro or Wegovy, focus on which treatment aligns with your lifestyle, medical profile, and preferences as assessed by a qualified prescriber. Both treatments are available from EverydayMeds with the same high standards of clinical oversight, cold-chain delivery, and ongoing support throughout your weight management journey. Use discount codes FIRST40 for new customers or DOSE25 for returning patients to access either treatment at our published pricing from £79.99. Your prescriber can help determine which mechanism, dosing schedule, and practical considerations best suit your individual circumstances. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and access both Wegovy and Mounjaro through our comprehensive weight management programme. Both represent significant advances in prescription weight management, and the "better" choice is ultimately the one that works effectively and sustainably for your unique situation.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
